Talk Around Town: SpaceX CRS-35 May Be Hauling the Future of Medicine to the ISS

What Folks Are Sayin' Down at the Feed Store

Well, slap the hood of a pickup and call it a spaceship — word comin' out of Cape Canaveral on October 13, 2026, is that a SpaceX Falcon 9 rocket hauled a Dragon capsule into orbit like a hound dog late for supper. NASA reports the launch occurred at approximately 6:33 a.m. EDT from Cape Canaveral Space Force Station, marking SpaceX's 35th commercial cargo run to the International Space Station. Space.com independently corroborates the launch time, payload mass, and key cargo details, so this ain't just one fella's tall tale.

NASA says the Dragon is lugging more than 6,300 pounds of science gear, crew supplies, and hardware — enough to fill a respectable barn loft. The buzz around the space community is that this particular haul has more potential medical mojo packed into it than just about any prior resupply run, though what all that potential actually turns into is about as clear right now as pond water after a rainstorm.

What We Actually Know for Certain

Here's the hard lumber in this here woodpile: NASA confirms the Dragon launched atop a Falcon 9 and is scheduled to arrive at the station around 11 a.m. on Thursday, October 15. As of research time, docking had not yet been confirmed, so hold your horses on the victory lap. The launch itself, the payload weight, and the basic manifest are all mutually corroborated by NASA's official mission blog and Space.com's independent reporting.

NASA reports that tucked inside that Dragon is hardware intended to manufacture artificial retinas in microgravity — the aim being to one day help restore vision back here on Earth — along with 3D heart tissue models that NASA says are meant to advance large-scale drug testing on future missions. Space.com further reports that the manifest includes brain organoids that researchers hope could point toward treatment targets for neurodegenerative diseases such as Alzheimer's, Parkinson's, and multiple sclerosis, plus materials to study how a new type of glass forms in the weightless environment.

Also on board, NASA and Space.com both confirm: the final pair of ISS Roll-Out Solar Arrays, known as iROSAs, which spacewalking crew members are expected to install to boost the station's power generation capacity. That's a concrete infrastructure upgrade, not just science speculation — though installation still lies ahead.

What the Crew Was Up to While Waitin' on the Truck

While Dragon was still makin' its way upstairs, the seven-member Expedition 75 crew wasn't exactly sittin' on the porch picking a banjo. NASA reports that NASA astronauts Anil Menon, Jessica Watkins, and Luke Delaney used a medical imaging device to conduct eye checks, helping ground doctors understand how microgravity affects the retina, cornea, and lens. That's the kind of work that makes the artificial retina research arriving on CRS-35 feel a little less like science fiction and a little more like a deliberate two-step.

NASA also reports that CSA astronaut Joshua Kutryk spent part of the day wearing what's called the Bio-Monitor vest and headband — a wearable system designed to track a crew member's comprehensive health data continuously while living and working aboard the station. If that sounds like something your smartwatch wishes it could be when it grows up, well, you ain't wrong.

According to an AIAA summary citing ISS National Lab's publication, the broader Expedition 75 and Crew-13 research agenda spans biomanufacturing, regenerative medicine, physical sciences, technology development, and student-led experiments. NASA's own Crew-13 coverage adds that the crew is tasked with using microgravity to produce human stem cell-derived tissues intended to support personalized medicine, disease modeling, and pharmaceutical screening for conditions including heart disease and Parkinson's disease.

What Ain't Been Proven Yet — and That's a Lot

Now here's where a sensible fella pumps the brakes before drivin' off a cliff. Every single one of these experiments — the retinas, the heart tissue, the brain organoids, the fancy glass — is in its early in-orbit phase. NASA has confirmed the hardware is headed upstairs; nobody has confirmed that any of it works as hoped. Medical applications on Earth from microgravity research have historically taken many years to materialize, if they materialize at all, and there's no guarantee these experiments produce results worth writing home about.

Docking itself, scheduled for October 15, had not been confirmed at the time this piece was put together. Space travel being the ornery mule that it is, we are not in the habit of counting cargo until it's latched on. Everything downstream of the Dragon's successful arrival — installation, activation, actual experimental results — remains entirely ahead of us and unverified.

Editorial Analysis: The Biggest Lunch Pail the ISS Has Seen in a Spell

This here section is analysis, not news reporting, so put on your thinking hat and keep that in mind. If the manifest holds together and the experiments go as the research teams are hoping — two considerable 'ifs' — CRS-35 could represent a genuine concentration of biomedical ambition on a single resupply flight. The combination of retinal manufacturing hardware, cardiac tissue modeling, neurological organoids, and wearable crew health monitoring on one mission looks less like coincidence and more like NASA and its partners are trying to turn the ISS into something resembling a floating medical research campus.

The iROSA solar arrays add a practical dimension too: more power capacity means more capability to run energy-hungry research equipment, which could matter a great deal for the kinds of biomanufacturing processes being discussed. Whether any of this eventually translates into treatments that help actual human beings down here in the dirt is a question that only years of follow-on research can answer. But as bets on the future go, this one at least has its boots on the right feet. Don't go sellin' your earthside doctor just yet, though.